From oncolytic peptides to oncolytic polymers: A new paradigm for oncotherapy

From oncolytic peptides to oncolytic polymers: A new paradigm for oncotherapy

Traditional cancer therapy methods, especially those directed against specific intracellular targets or signaling pathways, are not powerful enough to overcome tumor heterogeneity and therapeutic resistance. Oncolytic peptides that can induce membrane lysis-mediated cancer cell death and subsequent...

Full description

Bibliographic Details
Main Authors:	Hanmeng Liu, Wei Shen, Wanguo Liu, Zexin Yang, Dengke Yin, Chunsheng Xiao
Format:	Article
Language:	English
Published:	KeAi Communications Co., Ltd. 2024-01-01
Series:	Bioactive Materials
Subjects:	Oncolytic polymers Oncolytic peptides Cancer therapy Therapeutic resistance Immunotherapy
Online Access:	http://www.sciencedirect.com/science/article/pii/S2452199X23002475

Similar Items

Perspectives on immunotherapy via oncolytic viruses
by: Alberto Reale, et al.
Published: (2019-02-01)

Oncolytic Viral Therapy in Osteosarcoma
by: Thomas Karadimas, et al.
Published: (2024-07-01)

Recent progress in combination therapy of oncolytic vaccinia virus
by: Seyedeh Nasim Mirbahari, et al.
Published: (2024-03-01)

Neutrophils in oncolytic virus immunotherapy
by: Danya Zhou, et al.
Published: (2024-12-01)

Translation of oncolytic viruses in sarcoma
by: Steven I. Robinson, et al.
Published: (2024-09-01)

The Continued Promise and Many Disappointments of Oncolytic Virotherapy in Gastrointestinal Malignancies
by: Daniel H. Ahn, et al.
Published: (2017-03-01)

Oncolytic peptide LTX-315 induces an immune-mediated abscopal effect in a rat sarcoma model
by: Janne Nestvold, et al.
Published: (2017-08-01)

Biosafety and biohazard considerations of HSV-1–based oncolytic viral immunotherapy
by: Elizabeth Robilotti, et al.
Published: (2023-09-01)

From Benchtop to Bedside: A Review of Oncolytic Virotherapy
by: Audrey H. Choi, et al.
Published: (2016-08-01)

Oncolytic viruses as anticancer vaccines
by: Norman eWoller, et al.
Published: (2014-07-01)

Chemotherapy and Oncolytic Virotherapy: Advanced Tactics in the War against Cancer
by: Andrew eNguyen, et al.
Published: (2014-06-01)

A practical guide to the handling and administration of personalized transcriptionally attenuated oncolytic adenoviruses (PTAVs)
by: Christopher Larson, et al.
Published: (2018-09-01)

Oncolytic Viruses as an Adjunct to Immune Checkpoint Inhibition
by: Jacob Ripp, et al.
Published: (2022-05-01)

To Infection and Beyond: The Multi-Pronged Anti-Cancer Mechanisms of Oncolytic Viruses
by: Kevin A. Cassady, et al.
Published: (2016-02-01)

Exploring the relationship between cancer metabolism and oncolytic adenoviruses
by: Dyer, A
Published: (2021)

Genetic Modifications That Expand Oncolytic Virus Potency
by: Francisca Cristi, et al.
Published: (2022-01-01)

Enhancing cancer therapy: the integration of oncolytic virus therapy with diverse treatments
by: Zhuo Yan, et al.
Published: (2024-07-01)

Oncolytic viruses for cancer immunotherapy
by: Otto Hemminki, et al.
Published: (2020-06-01)

Targeting Autophagy for Oncolytic Immunotherapy
by: Lulu Hu, et al.
Published: (2017-01-01)

Immunostimulatory Gene Therapy Using Oncolytic Viruses as Vehicles
by: Angelica Loskog
Published: (2015-11-01)

Delivery and Biosafety of Oncolytic Virotherapy
by: Lizhi Li, et al.
Published: (2020-04-01)

Expression of Oncolytic Adenovirus-Encoded RNAi Molecules Is Most Effective in a pri-miRNA Precursor Format
by: Tereza Brachtlova, et al.
Published: (2020-12-01)

Strategies for Advanced Oncolytic Virotherapy: Current Technology Innovations and Clinical Approaches
by: Qing Ji, et al.
Published: (2022-08-01)

Giving Oncolytic Viruses a Free Ride: Carrier Cells for Oncolytic Virotherapy
by: Alberto Reale, et al.
Published: (2021-12-01)

Targeting Cancers with oHSV-Based Oncolytic Viral Immunotherapy
by: Rakin Tammam Nasar, et al.
Published: (2024-06-01)

Oncolytic virus immunotherapy: future prospects for oncology
by: Junaid Raja, et al.
Published: (2018-12-01)

Combining of Oncolytic Virotherapy and Other Immunotherapeutic Approaches in Cancer: A Powerful Functionalization Tactic
by: Hai Zou, et al.
Published: (2023-01-01)

Oncolytic herpes simplex virus and immunotherapy
by: Wenqing Ma, et al.
Published: (2018-12-01)

Portrait of a Leader in Immunotherapeutics<subtitle>Oncolytic viruses for treatment of cancer</subtitle>
by: Akseli Hemminki
Published: (2012-08-01)

Oncolytic virotherapy reverses the immunosuppressive tumor microenvironment and its potential in combination with immunotherapy
by: Yalei Zhang, et al.
Published: (2021-05-01)

Oncolytics, Cancer-Fighting Viruses from Past to Future: A Literature Review
by: Seyedeh Nasim Mirbahari, et al.
Published: (2024-03-01)

Oncolytic Viro-Immunotherapy: An Emerging Option in the Treatment of Gliomas
by: Jiayi Zeng, et al.
Published: (2021-10-01)

Recent advances in oncolytic virus therapy for hepatocellular carcinoma
by: Licheng Zhu, et al.
Published: (2023-04-01)

Oncolytic adenoviruses coated with MHC-I tumor epitopes increase the antitumor immunity and efficacy against melanoma
by: Cristian Capasso, et al.
Published: (2016-04-01)

Challenges and strategies toward oncolytic virotherapy for leptomeningeal metastasis
by: Jia-Li Zhao, et al.
Published: (2024-11-01)

Lung cancer and oncolytic virotherapy——enemy's enemy
by: Zhang Li, et al.
Published: (2023-01-01)

Research progress in the treatment of glioblastoma by an oncolytic virus: A narrative review
by: Xiangxiang Shao, et al.
Published: (2023-01-01)

Efficacy and safety of oncolytic virus combined with chemotherapy or immune checkpoint inhibitors in solid tumor patients: A meta-analysis
by: Xiangxing Liu, et al.
Published: (2022-11-01)

Immunotherapeutic Potential of Oncolytic H-1 Parvovirus: Hints of Glioblastoma Microenvironment Conversion towards Immunogenicity
by: Assia L. Angelova, et al.
Published: (2017-12-01)

Oncolytic viruses in melanoma
by: Camille Robinson, et al.
Published: (2022-02-01)